# Grace Therapeutics, Inc.: Form 8-K, filed Sep 18, 2025

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2025-09-18
- Accepted by EDGAR: Sep 18, 2025, 08:43 ET
- Period: 2025-09-18
- Accession: 0001140361-25-035337
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000114036125035337/ef20055717_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000114036125035337/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000114036125035337/ef20055717_8k.htm

Filed Sep 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-035337. Last ingested by Listed: Oct 26, 2026, 18:07 ET. No prices; not investment advice.
